Retrospective study of cisplatin plus radiotherapy toxicities in locally advanced squamous cell carcinoma of the head and neck – ReCisTT study
Despite the high treatment compliance, 62.6% of adverse events reported were related to cisplatin. Identifying risk factors associated with non-compliance could enable physicians to identify ineligible patients for cisplatin-based RCT and prevent patients from receiving inadequate treatment leading to severe adverse events..
Authors
- Ana Medina (ORCID: https://orcid.org/0000-0003-2961-1529)
- R. Giglio
- Joana Marinho (ORCID: https://orcid.org/0000-0003-3665-4666)
- Ana Macedo (ORCID: https://orcid.org/0000-0002-6978-8989)
- Thiago Bueno de Oliveira (ORCID: https://orcid.org/0000-0002-6472-3596)
- Amanda Psyrri (ORCID: https://orcid.org/0000-0002-4321-766X)
- Ana Varges Gomes
- Leticia Iglesias Rey
- Martín Ángel (ORCID: https://orcid.org/0000-0002-1463-8887)
- M. Plana Serrahima
- Gilberto de Castro (ORCID: https://orcid.org/0000-0001-8765-3044)
- Leonor Ribeiro (ORCID: https://orcid.org/0000-0002-7657-0902)
- Nicolas Magné
Institutions
- National and Kapodistrian University of Athens (GR)
- Universidad de Buenos Aires (AR)
- AC Camargo Hospital (BR)
- Institut d'Investigació Biomédica de Bellvitge (ES)
- Instituto do Câncer do Estado de São Paulo (BR)
- Centro Oncológico de Galicia (ES)
- Institut Català d'Oncologia (ES)
- Institute Cancer De La Loire Lucien Neuwirth (FR)
- Centro Hospitalar Lisboa Norte (PT)
- Algarve Biomedical Center (PT)
- Instituto Alexander Fleming (AR)
- Institut Bergonié (FR)
- University General Hospital Attikon (GR)
- Centro Hospitalar de Vila Nova de Gaia (PT)
- Complejo Hospitalario de Ourense (ES)
- University of Algarve (PT)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2024-10-14
- DOI
- https://doi.org/10.3389/fonc.2024.1220640
- Citations
- 3
- Primary Topic
- Head and Neck Cancer Studies
- Type
- article
- Field-Weighted Citation Impact
- 1.74
Funders
- Merck KGaA